Report overview
Antidiarrheal drugs are used to treat abrupt diarrhea and possess the mechanism of slowing down the movement of the gut and helps to diminish the number of bowel movements and also make the stools less watery. Distinct causes of diarrhea can be a virus such as a rotavirus, hepatitis, a bacterium such as E.coli, Shigella, and parasites causing amoebiasis and giardiasis. Majority of the events of diarrhea are recognized to be concluded with simple dietary modifications and may not require treatment, however, in certain cases of severe diarrhea, laboratory assessment is requisite which includes blood tests, and stool specimen evaluation to analyze the type of diarrhea.
This report contains market size and forecasts of Antidiarrheal Drugs in global, including the following market information:
Global Antidiarrheal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antidiarrheal Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Antidiarrheal Drugs companies in 2021 (%)
The global Antidiarrheal Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
OTC Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antidiarrheal Drugs include Johnson & Johnson, Novartis, GlaxoSmithKline, Proctor & Gamble, Pfizer, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antidiarrheal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antidiarrheal Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antidiarrheal Drugs Market Segment Percentages, by Type, 2021 (%)
OTC Drugs
Prescription Drugs
Global Antidiarrheal Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antidiarrheal Drugs Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Global Antidiarrheal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antidiarrheal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antidiarrheal Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antidiarrheal Drugs revenues share in global market, 2021 (%)
Key companies Antidiarrheal Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Antidiarrheal Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Novartis
GlaxoSmithKline
Proctor & Gamble
Pfizer
Actelion
Perrigo
Lupin
Glenmark Pharmaceuticals
Sanofi Aventis
Merck & Co.
Bayer
